Moderna Historical Financial Ratios


USD 149.95  7.10  4.97%   

Moderna is lately reporting on over 71 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Receivables Turnover of 7.7 will help investors to properly organize and evaluate Moderna financial condition quickly. Financial Statement Analysis is infinitely more than just reviewing and investigating Moderna recent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Moderna is a good buy for the upcoming year.
Additionally, see Stocks Correlation.

About Moderna Financial Ratios Analysis

ModernaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Moderna investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Moderna financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Moderna history.

Moderna Financial Ratios Chart

Moderna financial ratios usually calculated using numerical values taken directly from Moderna financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Moderna. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
Moderna PPandE Turnover is projected to increase significantly based on the last few years of reporting. The past year's PPandE Turnover was at 24.02. The current year Accounts Payable Turnover is expected to grow to 124.42, whereas Long Term Debt to Equity is forecasted to decline to 0.0349.

Return on Average Assets

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].

Return on Average Equity

Return on equity measures a corporation's profitability by calculating the amount of Net Income Common Stock returned as a percentage of [EquityAvg].

Return on Sales

Return on Sales is a ratio to evaluate a company's operational efficiency; calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont ROE analysis.
Most ratios from Moderna fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Moderna current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Additionally, see Stocks Correlation.Moderna PPandE Turnover is projected to increase significantly based on the last few years of reporting. The past year's PPandE Turnover was at 24.02. The current year Accounts Payable Turnover is expected to grow to 124.42, whereas Long Term Debt to Equity is forecasted to decline to 0.0349.
 2021 2022 (projected)
Calculated Tax Rate7.347.29
Long Term Debt to Equity0.04230.0349

Moderna fundamentals Correlations

Click cells to compare fundamentals

Moderna Account Relationship Matchups

Moderna fundamentals Accounts

201720182019202020212022 (projected)
Long Term Debt to Equity0.02510.02190.03290.04290.04230.0349
Cash Flow Per Share(5.08)(1.01)(1.36)5.0833.836.47
Revenue to Assets0.190.06880.03790.110.750.81
Total Assets Per Share16.635.974.7218.461.2166.04
Quick Ratio4.036.967.821.371.531.57
Net Current Assets as percentage of Total Assets54.5768.362.0226.0228.1444.17
Book Value per Share(8.55)18.863.556.7235.137.87
Current Ratio4.097.027.891.441.761.81
Debt to Equity Ratio(0.83)0.280.351.870.740.8
EBITDA Margin(1.14)(2.66)(8.07)(0.81)0.730.79
Earnings per Basic Share(4.18)(4.95)(1.55)(1.96)30.3132.71
Earnings per Diluted Share(4.18)(4.95)(1.55)(1.96)28.2930.52
Earnings per Basic Share USD(4.18)(4.95)(1.55)(1.96)30.3132.71
Free Cash Flow per Share(6.04)(5.38)(1.48)5.1433.0935.71
Profit Margin(1.31)(2.97)(8.57)(0.93)0.660.71
Return on Sales(1.24)(2.85)(8.58)(0.93)0.720.77
Sales per Share3.191.670.182.1145.8349.45
Tangible Assets Book Value per Share16.8124.194.819.2661.2166.04

Moderna Investors Sentiment

The influence of Moderna's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Moderna. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Moderna Implied Volatility

Moderna's implied volatility exposes the market's sentiment of Moderna stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Moderna's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Moderna stock will not fluctuate a lot when Moderna's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Moderna in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Moderna's short interest history, or implied volatility extrapolated from Moderna options trading.

Current Sentiment - MRNA

Moderna Investor Sentiment

Most of Macroaxis users are now bullish on Moderna. What is your trading attitude regarding investing in Moderna? Are you bullish or bearish?
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Moderna using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Moderna information on this page should be used as a complementary analysis to other Moderna's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Moderna Stock analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
59.6 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.